Aptamer/doxorubicin-conjugated nanoparticles target membranous CEMIP2 in colorectal cancer
- Type
- Correction
- Notice date
- 7/21/2023 0:00
- Journal
- International Journal of Biological Macromolecules
- Publisher
- Elsevier
- Notice DOI
- 10.1016/j.ijbiomac.2023.125782
- Original paper DOI
- 10.1016/j.ijbiomac.2023.125510